Novartis invested EUR 204m in Slovenia in 2020

Ljubljana, 26 January - The Swiss pharma giant Novartis continued to invest in its R&D and production capacities in Slovenia through its subsidiaries Lek, Sandoz and Novartis Pharma Services last year. Despite the Covid-19 epidemic, it invested EUR 204 million in the country, show figures presented on Tuesday.

Lek HQ in Ljubljana
Photo: Tamino Petelinšek/STA
File photo

The rest of this news item is available to subscribers.
The news item consists of 762 characters (without spaces) or 146 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2021